CME Group (CME) just moved into AI infrastructure finance, partnering with Silicon Data to launch what is described as the first compute futures market so investors can manage GPU price volatility.

Against that backdrop, CME Group’s share price is at US$297.70, with a year to date share price return of 10.39% and a 1 year total shareholder return of 12.81%. The 3 year total shareholder return of 86.36% points to momentum that has built over a longer horizon, despite a modest 90 day share price decline of 1.77%.

If this move into AI infrastructure finance has your attention, it could be a good moment to look across the broader AI supply chain using our dedicated screener for 39 AI infrastructure stocks

With CME Group trading close to the average analyst price target and showing strong multi year shareholder returns, the key question now is whether the new compute futures opportunity is still underappreciated or already fully priced in.

Most Popular Narrative: 3.4% Undervalued

The most followed narrative currently places CME Group’s fair value at $308.20, slightly above the last close of $297.70, which implies modest upside based on its long term earnings and cash generation profile under that framework.

The ongoing global shift toward electronic trading, greater regulatory demands for transparency and standardized clearing, and a proven ability to grow non-transactional revenue (e.g., record market data revenue) position CME to capture a larger share of trading activity and support durable long-term earnings growth.

Curious what kind of revenue path and margin structure need to line up for that fair value to hold. The narrative leans on measured growth, strong profitability, and a future earnings multiple that contrasts sharply with today’s market assumptions. The tension between higher long term earnings and only a small valuation gap is where the story gets interesting.

Result: Fair Value of $308.20 (UNDERVALUED)

However, this hinges on trading activity holding up, and risks like lower market volatility or tougher regulation on derivatives could quickly challenge those fair value assumptions.

Another View: Multiples Send A Different Signal

The narrative based on long term earnings and cash flow points to modest undervaluation, but the current 25.4x P/E sits above a fair ratio of 15.4x, even if it is slightly below the Capital Markets industry average of 41.8x and close to peers at 26.2x. That gap suggests less of a straightforward bargain and more of a debate about how much quality investors are willing to pay up for.

For a closer look at how this P/E gap could close over time, and what that might mean for valuation risk versus opportunity, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If the mix of opportunity and concern around CME Group feels finely balanced, it may be worth reviewing the data yourself and acting while views are still forming. You can start with 2 key rewards and 2 important warning signs.

Looking for more investment ideas?

If you are weighing CME Group and similar opportunities, do not stop here. Broaden your watchlist now so you are not late to the next move.

• Spot potential bargains early by scanning 47 high quality undervalued stocks that combine quality fundamentals with pricing that may not fully reflect them yet.
• Build a steadier income stream by reviewing 13 dividend fortresses that focus on higher yields supported by underlying cash flows.
• Sleep easier at night by zeroing in on 67 resilient stocks with low risk scores designed to highlight companies with lower overall risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.